Friday, October 30, 2026

Nokia Stock Was 11.58% Up On Thursday

ViaNews Editorial Team

January 25, 2024

Nokia Stock Was 11.58% Up On Thursday

(VIANEWS) - The NYSE ended the session with Nokia jumping 11.58% to $3.81 on Thursday, after two sequential sessions in a row of gains. NYSE rose 0.57% to $16,865.16, following the last session's downward trend on what was a somewhat bullish trend exchanging session today.

Nokia's last close was $3.41, 31.39% under its 52-week high of $4.97.

About Nokia

Nokia Oyj provides mobile, fixed, and cloud network solutions worldwide. The company operates through four segments: Network Infrastructure, Mobile Networks, Cloud and Network Services, and Nokia Technologies. It offers products and services for radio access networks and microwave radio links for transport networks, and solutions for network management, as well as network planning, optimization, network deployment, and technical support services. The company provides fixed networking solutions, such as fiber and copper-based access infrastructure, Wi-Fi in-home solutions, and cloud and virtualization services; IP networking solutions, including IP access, aggregation, and edge and core routing for residential, business, mobile, cloud, and digital industry applications, as well as software-defined WAN solutions; a portfolio of optical networks comprising portfolio coherent optical transponders, optical transport network switchers, wavelength-division multiplexers, reconfigurable optical add-drop multiplexer solutions, and optical line systems for metro, regional, long-haul and ultra-long-haul applications; and submarine networks. In addition, it offers cloud and network services, including core network solutions, such as voice and packet core; business applications, which covers security, automation, and monetization; cloud and cognitive services; and enterprise solutions covering private wireless and industrial automation. Further, the company provides hardware, software, and services, as well as licensing of intellectual property, including patents, technologies, and the Nokia brand. It serves communications service providers, webscales, hyperscalers, digital developer, partner, and government. Nokia Oyj was founded in 1865 and is headquartered in Espoo, Finland.

Earnings Per Share

As for profitability, Nokia has a trailing twelve months EPS of $0.75.

PE Ratio

Nokia has a trailing twelve months price to earnings ratio of 5.07. Meaning, the purchaser of the share is investing $5.07 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.78%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Nokia's EBITDA is 36.3.

Moving Average

Nokia's worth is way above its 50-day moving average of $3.40 and below its 200-day moving average of $3.82.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Oct 22, 2023, the estimated forward annual dividend rate is 0.13 and the estimated forward annual dividend yield is 3.73%.

More news about Nokia (NOK).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com